5 Key Takeaways

• 1

  A systematic review analyzed 14 trials on polyphenol supplements for preeclampsia, led by Phi-Yen Nguyen from the Burnet Institute.

• 2

  EGCG and resveratrol combined with nifedipine reduced time to blood pressure control and prolonged time to the next hypertensive crisis.

• 3

  Both findings regarding EGCG and resveratrol were classified as low-certainty evidence, indicating limited reliability.

• 4

  No significant differences were found for other polyphenol interventions, and no clear evidence of reduced maternal or neonatal complications was reported.

• 5

  Current evidence does not support widespread polyphenol use for preeclampsia, highlighting the need for large-scale trials to assess safety and efficacy.